Clonidine Hydrochloride 0.3 MG Oral Tablet
INDICATIONS AND USAGE Clonidine hydrochloride tablets are indicated in the treatment of hypertension. Clonidine hydrochloride tablets may be employed alone or concomitantly with other antihypertensive agents.
actavis pharma, inc.
Related Pills
clonidine hydrochloride tablet
actavis pharma, inc.
clonidine hydrochloride tablet
actavis pharma, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
CLONIDINE HYDROCHLORIDE tablets, USP are supplied as follows: 0.1 mg - Each orange, round tablet imprinted with and 127 on one side and bisect on the other side contains 0.1 mg of
CLONIDINE HYDROCHLORIDE, USP and is supplied in bottles of 100 (NDC 0228-2127-10) and 500 (NDC 0228-2127-50). 0.2 mg - Each orange, round tablet imprinted with on one side and 128 and bisect on the other side contains 0.2 mg of
CLONIDINE HYDROCHLORIDE, USP and is supplied in bottles of 100 (NDC 0228-2128-10) and 500 (NDC 0228-2128-50). 0.3 mg - Each orange, round tablet imprinted with on one side and 129 and bisect on the other side contains 0.3 mg of
CLONIDINE HYDROCHLORIDE, USP and is supplied in bottles of 100 (NDC 0228-2129-10). Dispense in a tight, light-resistant container as defined in the USP. Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Manufactured In Croatia By: Pliva Hrvatska d.o.o. Zagreb, Croatia Manufactured For: Teva Pharmaceuticals Parsippany, NJ 07054 Rev. A 9/2022 0.1 mg image 0.2mg image 0.3mg image
More pills like ROUND R 129